Quarterly report · Q2
2370.TEDINET S100TF3G
Period2023-10-01 → 2024-03-31
Filed2024-05-14
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥400m | 2023-10-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥662m | 2022-10-01 → 2023-09-30 | Standalone | Net sales (5-year summary) |
| Revenue | ¥349m | 2022-10-01 → 2023-03-31 | Standalone | Net sales |
| Operating income | −¥659m | 2023-10-01 → 2024-03-31 | Standalone | Operating income |
| Operating income | −¥672m | 2022-10-01 → 2023-03-31 | Standalone | Operating income |
| Ordinary income | −¥633m | 2023-10-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥1.4bn | 2022-10-01 → 2023-09-30 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥670m | 2022-10-01 → 2023-03-31 | Standalone | Ordinary income |
| Profit before tax | −¥633m | 2023-10-01 → 2024-03-31 | Standalone | Income before income taxes |
| Profit before tax | −¥674m | 2022-10-01 → 2023-03-31 | Standalone | Income before income taxes |
| Net income | −¥634m | 2023-10-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | −¥1.4bn | 2022-10-01 → 2023-09-30 | Standalone | Net income loss (5-year summary) |
| Net income | −¥677m | 2022-10-01 → 2023-03-31 | Standalone | Profit loss |
| Total assets | ¥6.1bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥5.6bn | at 2023-09-30 | Standalone | Assets |
| Total assets | ¥5.4bn | at 2023-03-31 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥533m | at 2024-03-31 | Standalone | Liabilities |
| Total liabilities | ¥590m | at 2023-09-30 | Standalone | Liabilities |
| Net assets / equity | ¥5.6bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥5.0bn | at 2023-09-30 | Standalone | Net assets |
| Net assets / equity | ¥4.9bn | at 2023-03-31 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥4.9bn | at 2024-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥4.4bn | at 2023-09-30 | Standalone | Cash and deposits |
| Cash & equivalents | ¥4.9bn | at 2024-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥4.4bn | at 2023-09-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥4.0bn | at 2023-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥4.5bn | at 2022-09-30d | Standalone | Cash and cash equivalents |
| Operating cash flow | −¥573m | 2023-10-01 → 2024-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥1.3bn | 2022-10-01 → 2023-09-30 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥564m | 2022-10-01 → 2023-03-31 | Standalone | Net cash provided by used in operating activities |
| Investing cash flow | −¥17m | 2023-10-01 → 2024-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | ¥3m | 2022-10-01 → 2023-09-30 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥35m | 2022-10-01 → 2023-03-31 | Standalone | Net cash provided by used in investment activities |
| Financing cash flow | ¥1.1bn | 2023-10-01 → 2024-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.2bn | 2022-10-01 → 2023-09-30 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥133m | 2022-10-01 → 2023-03-31 | Standalone | Net cash provided by used in financing activities |
| EPS (basic) | ¥-2.55 | 2023-10-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-1.34 | 2024-01-01 → 2024-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-6.65 | 2022-10-01 → 2023-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-3.19 | 2022-10-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-1.66 | 2023-01-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Equity ratio | 91.2% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 89.2% | at 2023-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 89.6% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 256,190,306 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 232,160,757 | at 2023-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 213,465,757 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2023-10-01 → 2024-03-31 | −¥286m |
| jpcrp040300-q2r_E05351-000Cellular And Tissue Based Product Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥166,000 |
| jpcrp040300-q2r_E05351-000Cellular And Tissue Based Product Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥166,000 |
| jpcrp040300-q2r_E05351-000Cellular And Tissue Based Product Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | −¥219m |
| jpcrp040300-q2r_E05351-000Contract Cell Manufacturing Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥400m |
| jpcrp040300-q2r_E05351-000Contract Cell Manufacturing Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥400m |
| jpcrp040300-q2r_E05351-000Contract Cell Manufacturing Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | −¥154m |
| —segment total | revenue | 2023-10-01 → 2024-03-31 | ¥400m |
| —segment total | revenue external | 2023-10-01 → 2024-03-31 | ¥400m |
| —segment total | segment profit | 2023-10-01 → 2024-03-31 | −¥373m |
| Reconciling Itemsreconciling | segment profit | 2022-10-01 → 2023-03-31 | −¥313m |
| jpcrp040300-q2r_E05351-000Cellular And Tissue Based Product Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥276,000 |
| jpcrp040300-q2r_E05351-000Cellular And Tissue Based Product Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥276,000 |
| jpcrp040300-q2r_E05351-000Cellular And Tissue Based Product Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | −¥225m |
| jpcrp040300-q2r_E05351-000Contract Cell Manufacturing Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥349m |
| jpcrp040300-q2r_E05351-000Contract Cell Manufacturing Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥349m |
| jpcrp040300-q2r_E05351-000Contract Cell Manufacturing Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | −¥133m |
| —segment total | revenue | 2022-10-01 → 2023-03-31 | ¥349m |
| —segment total | revenue external | 2022-10-01 → 2023-03-31 | ¥349m |
| —segment total | segment profit | 2022-10-01 → 2023-03-31 | −¥358m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 463
| Item | Context | Value | Unit |
|---|---|---|---|
| Cash and deposits | CurrentQuarterInstant_NonConsolidatedMember | 4901287000 | JPY |
| Accounts receivable trade | Prior1YearInstant_NonConsolidatedMember | 217624000 | JPY |
| Accounts receivable trade | CurrentQuarterInstant_NonConsolidatedMember | 204451000 | JPY |
| Work in process | Prior1YearInstant_NonConsolidatedMember | 33741000 | JPY |
| Work in process | CurrentQuarterInstant_NonConsolidatedMember | 18789000 | JPY |
| Raw materials and supplies | Prior1YearInstant_NonConsolidatedMember | 33740000 | JPY |
| Raw materials and supplies | CurrentQuarterInstant_NonConsolidatedMember | 33107000 | JPY |
| Other ca | Prior1YearInstant_NonConsolidatedMember | 88217000 | JPY |
| Other ca | CurrentQuarterInstant_NonConsolidatedMember | 48914000 | JPY |
| Allowance for doubtful accounts ca | Prior1YearInstant_NonConsolidatedMember | -828000 | JPY |
| Allowance for doubtful accounts ca | CurrentQuarterInstant_NonConsolidatedMember | - | JPY |
| Current assets | Prior1YearInstant_NonConsolidatedMember | 4768828000 | JPY |
| Current assets | CurrentQuarterInstant_NonConsolidatedMember | 5206551000 | JPY |
| Buildings net | Prior1YearInstant_NonConsolidatedMember | 404826000 | JPY |
| Buildings net | CurrentQuarterInstant_NonConsolidatedMember | 372718000 | JPY |
| Other net ppe | Prior1YearInstant_NonConsolidatedMember | 73575000 | JPY |
| Other net ppe | CurrentQuarterInstant_NonConsolidatedMember | 86167000 | JPY |
| Property plant and equipment | Prior1YearInstant_NonConsolidatedMember | 478402000 | JPY |
| Property plant and equipment | CurrentQuarterInstant_NonConsolidatedMember | 458886000 | JPY |
| Intangible assets | Prior1YearInstant_NonConsolidatedMember | 113248000 | JPY |
| Intangible assets | CurrentQuarterInstant_NonConsolidatedMember | 109145000 | JPY |
| Investment securities | Prior1YearInstant_NonConsolidatedMember | 211666000 | JPY |
| Investment securities | CurrentQuarterInstant_NonConsolidatedMember | 263682000 | JPY |
| Long term loans receivable | Prior1YearInstant_NonConsolidatedMember | 531250000 | JPY |
| Long term loans receivable | CurrentQuarterInstant_NonConsolidatedMember | 528750000 | JPY |
| Other ioa | Prior1YearInstant_NonConsolidatedMember | 90604000 | JPY |
| Other ioa | CurrentQuarterInstant_NonConsolidatedMember | 87078000 | JPY |
| Allowance for doubtful accounts ioa by group | Prior1YearInstant_NonConsolidatedMember | -559855000 | JPY |
| Allowance for doubtful accounts ioa by group | CurrentQuarterInstant_NonConsolidatedMember | -553828000 | JPY |
| Investments and other assets | Prior1YearInstant_NonConsolidatedMember | 273666000 | JPY |
| Investments and other assets | CurrentQuarterInstant_NonConsolidatedMember | 325681000 | JPY |
| Noncurrent assets | Prior1YearInstant_NonConsolidatedMember | 865316000 | JPY |
| Noncurrent assets | CurrentQuarterInstant_NonConsolidatedMember | 893713000 | JPY |
| Assets | Prior1YearInstant_NonConsolidatedMember | 5634145000 | JPY |
| Assets | CurrentQuarterInstant_NonConsolidatedMember | 6100265000 | JPY |
| Accounts payable trade | Prior1YearInstant_NonConsolidatedMember | 55217000 | JPY |
| Accounts payable trade | CurrentQuarterInstant_NonConsolidatedMember | 46644000 | JPY |
| Income taxes payable | Prior1YearInstant_NonConsolidatedMember | 18323000 | JPY |
| Income taxes payable | CurrentQuarterInstant_NonConsolidatedMember | 21639000 | JPY |
| Provision for bonuses | Prior1YearInstant_NonConsolidatedMember | 61723000 | JPY |
| Provision for bonuses | CurrentQuarterInstant_NonConsolidatedMember | 62436000 | JPY |
| Other cl | Prior1YearInstant_NonConsolidatedMember | 211574000 | JPY |
| Other cl | CurrentQuarterInstant_NonConsolidatedMember | 126024000 | JPY |
| Current liabilities | Prior1YearInstant_NonConsolidatedMember | 346838000 | JPY |
| Current liabilities | CurrentQuarterInstant_NonConsolidatedMember | 256745000 | JPY |
| Asset retirement obligations ncl | Prior1YearInstant_NonConsolidatedMember | 158146000 | JPY |
| Asset retirement obligations ncl | CurrentQuarterInstant_NonConsolidatedMember | 159148000 | JPY |
| Provision for share based payments ncl | Prior1YearInstant_NonConsolidatedMember | 19133000 | JPY |
| Provision for share based payments ncl | CurrentQuarterInstant_NonConsolidatedMember | 31818000 | JPY |
| Other ncl | Prior1YearInstant_NonConsolidatedMember | 66085000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |